BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 15570998)

  • 21. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of chronic hepatitis C virus infection.
    Nelson DR; Lau JY
    Antivir Ther; 1998; 3(Suppl 3):25-35. PubMed ID: 10726053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
    Golden-Mason L; Rosen HR
    Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
    Pham TN; Mercer SE; Michalak TI
    J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopathogenesis in hepatitis C virus cirrhosis.
    Spengler U; Nattermann J
    Clin Sci (Lond); 2007 Feb; 112(3):141-55. PubMed ID: 17199558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
    Cerny A; Chisari FV
    Hepatology; 1999 Sep; 30(3):595-601. PubMed ID: 10462362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
    Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
    J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
    Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
    J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
    Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
    J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of antigen-presenting cell functions by alcohol: implications for hepatitis C virus infection.
    Szabo G; Dolganiuc A; Mandrekar P; White B
    Alcohol; 2004 Jul; 33(3):241-9. PubMed ID: 15596093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
    Moorman JP; Joo M; Hahn YS
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of hepatitis C virus infection and related liver disease.
    Pawlotsky JM
    Trends Microbiol; 2004 Feb; 12(2):96-102. PubMed ID: 15036326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host factors involved in the replication of hepatitis C virus.
    Moriishi K; Matsuura Y
    Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients.
    Janvier G; Chaix ML; Fontaine H; Bresson JL; Pol S; Riviere Y
    Virology; 2005 Sep; 340(2):318-25. PubMed ID: 16054187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.